Role of Muc5b in Honeycomb Cyst Formation
Role of Muc5b in Honeycomb Cyst Formation
批准号:
9329207
负责人:
Jonathan Scott Kurche
金额:
$7.19万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2018-06-30
关键词:
Acute Lung InjuryAddressAffectAlveolarAnatomyBiochemistryBioinformaticsBiologyBleomycinBronchiolesCell Differentiation processCell LineCellsCiliaClinicalCystCytokeratinDataDevelopmentDiseaseEcologyEpithelialEpithelial CellsEpitheliumFibrosisFutureGelGene Expression ProfilingGenesGeneticGenetic PolymorphismGenetic RiskGenetically Engineered MouseGenomicsGoalsHamman-Rich syndromeHematopoietic Stem Cell MobilizationHumanHuman GeneticsHydroxyprolineInfluenzaInfluenza A Virus, H1N1 SubtypeInfluenza A virusInjuryInterstitial Lung DiseasesKnowledgeLeadLungLung diseasesMUC5B geneMentorsMentorshipMetaplasiaMicroscopicModelingMolecularMolecular BiologyMuc5B proteinMucinsMucous body substanceMusMutationPathogenesisPathway interactionsPharmacologyProductionPublicationsPulmonary FibrosisResearchRisk FactorsRoleScienceSignal TransductionStem cellsStructural defectTestingTrainingTransgenic MiceTransgenic OrganismsTranslatingVariantbasecareercell typecofactorexperimental studyfibrogenesisgain of functiongenetic approachgenetic variantinhibitor/antagonistinjury and repairlung injurymouse modelnotch proteinnovelnovel therapeuticsoverexpressionpromoterreconstitutionskills
中文摘要
项目摘要
这项提案的总体科学目标是建立在我们在MUC5B相关的特发性
肺纤维化(IPF),了解肺纤维化的基本机制。IPF是一种毁灭性的
这种疾病每年在全世界夺走500万人的生命。其特征在于进行性肺纤维化,
形成微观蜂窝(HC)囊肿。虽然最近已经有一些治疗方法,
IPF的治疗受限于我们对其病理生物学的理解。我们发现,
MUC5B基因上游3kb多态性是IPF发生的最强危险因素。在
在小鼠的初步实验中,我们证明了Muc5b的过表达导致了
博莱霉素和流感引起的纤维化。然而,Muc5b过度表达而不伴有肺损伤,
足以引起纤维化。IPF中的基因表达分析表明MUC5B与IPF的发病相关。
表达HC。同样,我们和其他人已经发现HC含有大量MUC5B蛋白。一
最近的一份出版物指出,小鼠在流感损伤的情况下会产生HC样囊肿,
其形成依赖于Notch发育途径。Notch信号也被证明是
对IPF中HC的形成很重要。我们发现,小鼠体内流感相关的HC样囊肿含有
在人肺上皮细胞系中,Notch抑制显著降低MUC5B
表情然而,NOTCH和MUC5B在IPF中的相互作用完全未知。鉴于明显的
Notch在Muc5b和HC样囊肿表达中的作用,以及Muc5b在人类和
在小鼠纤维化模型中,我们假设Notch调节肺损伤修复并促进肺纤维化。
纤维化通过下游Muc5b表达。在本提案的目标1中,我将为Notch确立一个角色,
肺纤维化和Muc5b表达通过测试Notch是否是必要的或足够的。在Aim中
2、我将评估Muc5b在纤维化中的必要性,并确定Muc5b对纤维化的影响是否与其对纤维化的影响有关。
上皮细胞固有的。这些目标解决了我们对IPF发病机制的认识存在的重大空白,特别是
这可能会导致新的治疗方法。在这个新项目中接受的培训将
提高我对分子生物学的理解,并与生物信息学的具体课程相结合,将
使我能够专注于间质性肺病的功能遗传学方法。
英文摘要
Project summary
The overall scientific goal of this proposal is to build upon our findings in MUC5B-associated idiopathic
pulmonary fibrosis (IPF) to understand the basic mechanisms of pulmonary fibrosis. IPF is a devastating
disease that claims 5 million lives worldwide annually. It is characterized by progressive lung fibrosis and
formation of microscopic honeycomb (HC) cysts. Although some therapies have recently become available,
treatment of IPF is limited by our understanding of its pathobiology. We have found that a gain-of-function
polymorphism 3kb upstream of the MUC5B gene is the strongest risk factor for development of IPF. In
preliminary experiments in mice, we demonstrate that overexpression of Muc5b leads to an enhancement of
fibrosis provoked by bleomycin and influenza. However, overexpression of Muc5b without lung injury is not
sufficient to provoke fibrosis. Gene expression analysis in IPF has demonstrated an association of MUC5B
expression with HC. Likewise, we and others, have discovered that HCs contain significant MUC5B protein. A
recent publication noted that mice develop HC-like cysts in the setting of influenza injury, and that cyst
formation depends on the Notch developmental pathway. Notch signals have also been demonstrated to be
important for HC formation in IPF. We have found that influenza-associated HC-like cysts in mice contain
copious Muc5b, and in human lung epithelial cell lines Notch inhibition significantly reduces MUC5B
expression. However, the interplay of NOTCH and MUC5B in IPF are completely unknown. Given the apparent
role of Notch in the expression of Muc5b and HC-like cysts, and the characterized role of Muc5b in human and
murine fibrosis models, we hypothesized that Notch modulates lung injury repair and promotes pulmonary
fibrosis through downstream Muc5b expression. In Aim 1 of this proposal, I will establish a role for Notch in
pulmonary fibrosis and Muc5b expression by testing whether Notch is necessary or sufficient for either. In Aim
2, I will evaluate the necessity of Muc5b in fibrosis, and determine whether effects of Muc5b on fibrosis are
epithelial-cell intrinsic. These Aims address significant gaps in our knowledge of IPF pathogenesis, particularly
where epithelia are concerned, and may lead to novel therapies. Training received during this novel project will
enhance my understanding of molecular biology, and, paired with specific coursework in bioinformatics, will
enable me to focus on functional genetic approaches to interstitial lung disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金